Efficacy	O
of	O
Synbiotics	B:C2936470
for	O
Treatment	O
of	O
Bacillary	O
Dysentery	I:C1527298
in	O
Children	O
:	O
A	O
Double	O
-	I:C0013072
Blind	I:C0013072
,	O
Randomized	O
,	O
Placebo	O
-	O
Controlled	O
Study	O
Bacillary	O
dysentery	I:C1527298
is	O
a	O
major	O
cause	O
of	O
children	O
's	O
admission	O
to	I:C0184666
hospitals	I:C0184666
.	O

Efficacy	O
of	O
Synbiotics	O
for	O
Treatment	B:C0087111
of	O
Bacillary	O
Dysentery	I:C1527298
in	O
Children	O
:	O
A	O
Double	O
-	I:C0013072
Blind	I:C0013072
,	O
Randomized	O
,	O
Placebo	O
-	O
Controlled	O
Study	O
Bacillary	O
dysentery	I:C1527298
is	O
a	O
major	O
cause	O
of	O
children	O
's	O
admission	O
to	I:C0184666
hospitals	I:C0184666
.	O

Efficacy	O
of	O
Synbiotics	O
for	O
Treatment	O
of	O
Bacillary	B:C1527298
Dysentery	I:C1527298
in	O
Children	O
:	O
A	O
Double	O
-	I:C0013072
Blind	I:C0013072
,	O
Randomized	O
,	O
Placebo	O
-	O
Controlled	O
Study	O
Bacillary	O
dysentery	I:C1527298
is	O
a	O
major	O
cause	O
of	O
children	O
's	O
admission	O
to	I:C0184666
hospitals	I:C0184666
.	O

Efficacy	O
of	O
Synbiotics	O
for	O
Treatment	O
of	O
Bacillary	O
Dysentery	I:C1527298
in	O
Children	O
:	O
A	O
Double	B:C0013072
-	I:C0013072
Blind	I:C0013072
,	O
Randomized	O
,	O
Placebo	O
-	O
Controlled	O
Study	O
Bacillary	O
dysentery	I:C1527298
is	O
a	O
major	O
cause	O
of	O
children	O
's	O
admission	O
to	I:C0184666
hospitals	I:C0184666
.	O

Efficacy	O
of	O
Synbiotics	O
for	O
Treatment	O
of	O
Bacillary	O
Dysentery	I:C1527298
in	O
Children	O
:	O
A	O
Double	O
-	I:C0013072
Blind	I:C0013072
,	O
Randomized	B:C0206035
,	O
Placebo	O
-	O
Controlled	O
Study	O
Bacillary	O
dysentery	I:C1527298
is	O
a	O
major	O
cause	O
of	O
children	O
's	O
admission	O
to	I:C0184666
hospitals	I:C0184666
.	O

Efficacy	O
of	O
Synbiotics	O
for	O
Treatment	O
of	O
Bacillary	O
Dysentery	I:C1527298
in	O
Children	O
:	O
A	O
Double	O
-	I:C0013072
Blind	I:C0013072
,	O
Randomized	O
,	O
Placebo	O
-	O
Controlled	O
Study	O
Bacillary	B:C1527298
dysentery	I:C1527298
is	O
a	O
major	O
cause	O
of	O
children	O
's	O
admission	O
to	I:C0184666
hospitals	I:C0184666
.	O

Efficacy	O
of	O
Synbiotics	O
for	O
Treatment	O
of	O
Bacillary	O
Dysentery	I:C1527298
in	O
Children	O
:	O
A	O
Double	O
-	I:C0013072
Blind	I:C0013072
,	O
Randomized	O
,	O
Placebo	O
-	O
Controlled	O
Study	O
Bacillary	O
dysentery	I:C1527298
is	O
a	O
major	O
cause	O
of	O
children	O
's	O
admission	B:C0184666
to	I:C0184666
hospitals	I:C0184666
.	O

To	O
assess	O
the	O
probiotic	B:C0525033
and	O
prebiotic	O
(	O
synbiotics	O
)	O
effects	O
in	O
children	O
with	O
dysentery	O
in	O
a	O
randomized	O
clinical	I:C0206034
trial	I:C0206034
,	O
200	O
children	O
with	O
dysentery	O
were	O
studied	O
in	O
2	O
groups	O
:	O
the	O
synbiotic	O
group	O
received	O
1	O
tablet	O
/	O
day	O
of	O
synbiotic	O
for	O
3	O
-	O
5	O
days	O
and	O
the	O
placebo	O
group	O
received	O
placebo	O
tablets	O
(	O
identical	O
tablet	O
form	O
like	O
probiotics	O
)	O
.	O

To	O
assess	O
the	O
probiotic	O
and	O
prebiotic	B:C2717875
(	O
synbiotics	O
)	O
effects	O
in	O
children	O
with	O
dysentery	O
in	O
a	O
randomized	O
clinical	I:C0206034
trial	I:C0206034
,	O
200	O
children	O
with	O
dysentery	O
were	O
studied	O
in	O
2	O
groups	O
:	O
the	O
synbiotic	O
group	O
received	O
1	O
tablet	O
/	O
day	O
of	O
synbiotic	O
for	O
3	O
-	O
5	O
days	O
and	O
the	O
placebo	O
group	O
received	O
placebo	O
tablets	O
(	O
identical	O
tablet	O
form	O
like	O
probiotics	O
)	O
.	O

To	O
assess	O
the	O
probiotic	O
and	O
prebiotic	O
(	O
synbiotics	B:C2936470
)	O
effects	O
in	O
children	O
with	O
dysentery	O
in	O
a	O
randomized	O
clinical	I:C0206034
trial	I:C0206034
,	O
200	O
children	O
with	O
dysentery	O
were	O
studied	O
in	O
2	O
groups	O
:	O
the	O
synbiotic	O
group	O
received	O
1	O
tablet	O
/	O
day	O
of	O
synbiotic	O
for	O
3	O
-	O
5	O
days	O
and	O
the	O
placebo	O
group	O
received	O
placebo	O
tablets	O
(	O
identical	O
tablet	O
form	O
like	O
probiotics	O
)	O
.	O

To	O
assess	O
the	O
probiotic	O
and	O
prebiotic	O
(	O
synbiotics	O
)	O
effects	O
in	O
children	O
with	O
dysentery	B:C0013369
in	O
a	O
randomized	O
clinical	I:C0206034
trial	I:C0206034
,	O
200	O
children	O
with	O
dysentery	O
were	O
studied	O
in	O
2	O
groups	O
:	O
the	O
synbiotic	O
group	O
received	O
1	O
tablet	O
/	O
day	O
of	O
synbiotic	O
for	O
3	O
-	O
5	O
days	O
and	O
the	O
placebo	O
group	O
received	O
placebo	O
tablets	O
(	O
identical	O
tablet	O
form	O
like	O
probiotics	O
)	O
.	O

To	O
assess	O
the	O
probiotic	O
and	O
prebiotic	O
(	O
synbiotics	O
)	O
effects	O
in	O
children	O
with	O
dysentery	O
in	O
a	O
randomized	B:C0206034
clinical	I:C0206034
trial	I:C0206034
,	O
200	O
children	O
with	O
dysentery	O
were	O
studied	O
in	O
2	O
groups	O
:	O
the	O
synbiotic	O
group	O
received	O
1	O
tablet	O
/	O
day	O
of	O
synbiotic	O
for	O
3	O
-	O
5	O
days	O
and	O
the	O
placebo	O
group	O
received	O
placebo	O
tablets	O
(	O
identical	O
tablet	O
form	O
like	O
probiotics	O
)	O
.	O

To	O
assess	O
the	O
probiotic	O
and	O
prebiotic	O
(	O
synbiotics	O
)	O
effects	O
in	O
children	O
with	O
dysentery	O
in	O
a	O
randomized	O
clinical	I:C0206034
trial	I:C0206034
,	O
200	O
children	O
with	O
dysentery	B:C0013369
were	O
studied	O
in	O
2	O
groups	O
:	O
the	O
synbiotic	O
group	O
received	O
1	O
tablet	O
/	O
day	O
of	O
synbiotic	O
for	O
3	O
-	O
5	O
days	O
and	O
the	O
placebo	O
group	O
received	O
placebo	O
tablets	O
(	O
identical	O
tablet	O
form	O
like	O
probiotics	O
)	O
.	O

To	O
assess	O
the	O
probiotic	O
and	O
prebiotic	O
(	O
synbiotics	O
)	O
effects	O
in	O
children	O
with	O
dysentery	O
in	O
a	O
randomized	O
clinical	I:C0206034
trial	I:C0206034
,	O
200	O
children	O
with	O
dysentery	O
were	O
studied	O
in	O
2	O
groups	O
:	O
the	O
synbiotic	B:C2936470
group	O
received	O
1	O
tablet	O
/	O
day	O
of	O
synbiotic	O
for	O
3	O
-	O
5	O
days	O
and	O
the	O
placebo	O
group	O
received	O
placebo	O
tablets	O
(	O
identical	O
tablet	O
form	O
like	O
probiotics	O
)	O
.	O

To	O
assess	O
the	O
probiotic	O
and	O
prebiotic	O
(	O
synbiotics	O
)	O
effects	O
in	O
children	O
with	O
dysentery	O
in	O
a	O
randomized	O
clinical	I:C0206034
trial	I:C0206034
,	O
200	O
children	O
with	O
dysentery	O
were	O
studied	O
in	O
2	O
groups	O
:	O
the	O
synbiotic	O
group	O
received	O
1	O
tablet	B:C0039225
/	O
day	O
of	O
synbiotic	O
for	O
3	O
-	O
5	O
days	O
and	O
the	O
placebo	O
group	O
received	O
placebo	O
tablets	O
(	O
identical	O
tablet	O
form	O
like	O
probiotics	O
)	O
.	O

To	O
assess	O
the	O
probiotic	O
and	O
prebiotic	O
(	O
synbiotics	O
)	O
effects	O
in	O
children	O
with	O
dysentery	O
in	O
a	O
randomized	O
clinical	I:C0206034
trial	I:C0206034
,	O
200	O
children	O
with	O
dysentery	O
were	O
studied	O
in	O
2	O
groups	O
:	O
the	O
synbiotic	O
group	O
received	O
1	O
tablet	O
/	O
day	O
of	O
synbiotic	B:C2936470
for	O
3	O
-	O
5	O
days	O
and	O
the	O
placebo	O
group	O
received	O
placebo	O
tablets	O
(	O
identical	O
tablet	O
form	O
like	O
probiotics	O
)	O
.	O

To	O
assess	O
the	O
probiotic	O
and	O
prebiotic	O
(	O
synbiotics	O
)	O
effects	O
in	O
children	O
with	O
dysentery	O
in	O
a	O
randomized	O
clinical	I:C0206034
trial	I:C0206034
,	O
200	O
children	O
with	O
dysentery	O
were	O
studied	O
in	O
2	O
groups	O
:	O
the	O
synbiotic	O
group	O
received	O
1	O
tablet	O
/	O
day	O
of	O
synbiotic	O
for	O
3	O
-	O
5	O
days	O
and	O
the	O
placebo	B:C1696465
group	O
received	O
placebo	O
tablets	O
(	O
identical	O
tablet	O
form	O
like	O
probiotics	O
)	O
.	O

To	O
assess	O
the	O
probiotic	O
and	O
prebiotic	O
(	O
synbiotics	O
)	O
effects	O
in	O
children	O
with	O
dysentery	O
in	O
a	O
randomized	O
clinical	I:C0206034
trial	I:C0206034
,	O
200	O
children	O
with	O
dysentery	O
were	O
studied	O
in	O
2	O
groups	O
:	O
the	O
synbiotic	O
group	O
received	O
1	O
tablet	O
/	O
day	O
of	O
synbiotic	O
for	O
3	O
-	O
5	O
days	O
and	O
the	O
placebo	O
group	O
received	O
placebo	B:C1696465
tablets	O
(	O
identical	O
tablet	O
form	O
like	O
probiotics	O
)	O
.	O

To	O
assess	O
the	O
probiotic	O
and	O
prebiotic	O
(	O
synbiotics	O
)	O
effects	O
in	O
children	O
with	O
dysentery	O
in	O
a	O
randomized	O
clinical	I:C0206034
trial	I:C0206034
,	O
200	O
children	O
with	O
dysentery	O
were	O
studied	O
in	O
2	O
groups	O
:	O
the	O
synbiotic	O
group	O
received	O
1	O
tablet	O
/	O
day	O
of	O
synbiotic	O
for	O
3	O
-	O
5	O
days	O
and	O
the	O
placebo	O
group	O
received	O
placebo	O
tablets	B:C0039225
(	O
identical	O
tablet	O
form	O
like	O
probiotics	O
)	O
.	O

To	O
assess	O
the	O
probiotic	O
and	O
prebiotic	O
(	O
synbiotics	O
)	O
effects	O
in	O
children	O
with	O
dysentery	O
in	O
a	O
randomized	O
clinical	I:C0206034
trial	I:C0206034
,	O
200	O
children	O
with	O
dysentery	O
were	O
studied	O
in	O
2	O
groups	O
:	O
the	O
synbiotic	O
group	O
received	O
1	O
tablet	O
/	O
day	O
of	O
synbiotic	O
for	O
3	O
-	O
5	O
days	O
and	O
the	O
placebo	O
group	O
received	O
placebo	O
tablets	O
(	O
identical	O
tablet	B:C0039225
form	O
like	O
probiotics	O
)	O
.	O

To	O
assess	O
the	O
probiotic	O
and	O
prebiotic	O
(	O
synbiotics	O
)	O
effects	O
in	O
children	O
with	O
dysentery	O
in	O
a	O
randomized	O
clinical	I:C0206034
trial	I:C0206034
,	O
200	O
children	O
with	O
dysentery	O
were	O
studied	O
in	O
2	O
groups	O
:	O
the	O
synbiotic	O
group	O
received	O
1	O
tablet	O
/	O
day	O
of	O
synbiotic	O
for	O
3	O
-	O
5	O
days	O
and	O
the	O
placebo	O
group	O
received	O
placebo	O
tablets	O
(	O
identical	O
tablet	O
form	O
like	O
probiotics	B:C0525033
)	O
.	O

The	O
standard	O
treatment	B:C0087111
was	O
administered	O
for	O
all	O
patients	O
.	O

Duration	O
of	O
hospitalization	B:C0019993
,	O
dysentery	O
,	O
fever	O
,	O
and	O
the	O
weight	O
loss	I:C1262477
were	O
assessed	O
in	O
each	O
group	O
.	O

Duration	O
of	O
hospitalization	O
,	O
dysentery	B:C0013369
,	O
fever	O
,	O
and	O
the	O
weight	O
loss	I:C1262477
were	O
assessed	O
in	O
each	O
group	O
.	O

Duration	O
of	O
hospitalization	O
,	O
dysentery	O
,	O
fever	B:C0015967
,	O
and	O
the	O
weight	O
loss	I:C1262477
were	O
assessed	O
in	O
each	O
group	O
.	O

Duration	O
of	O
hospitalization	O
,	O
dysentery	O
,	O
fever	O
,	O
and	O
the	O
weight	B:C1262477
loss	I:C1262477
were	O
assessed	O
in	O
each	O
group	O
.	O

The	O
mean	O
duration	O
of	O
dysentery	B:C0013369
reduced	O
(	O
P	O
<	O
0.05	O
)	O
.	O

The	O
mean	O
duration	O
of	O
fever	B:C0015967
has	O
been	O
significantly	O
reduced	O
in	O
the	O
synbiotic	O
group	O
(	O
1.64	O
±	O
0.87	O
days	O
)	O
in	O
comparison	O
to	O
the	O
placebo	O
group	O
(	O
2.13	O
±	O
0.94	O
days	O
)	O
(	O
P	O
<	O
0.001	O
)	O
.	O

The	O
mean	O
duration	O
of	O
fever	O
has	O
been	O
significantly	O
reduced	O
in	O
the	O
synbiotic	B:C2936470
group	O
(	O
1.64	O
±	O
0.87	O
days	O
)	O
in	O
comparison	O
to	O
the	O
placebo	O
group	O
(	O
2.13	O
±	O
0.94	O
days	O
)	O
(	O
P	O
<	O
0.001	O
)	O
.	O

The	O
mean	O
duration	O
of	O
fever	O
has	O
been	O
significantly	O
reduced	O
in	O
the	O
synbiotic	O
group	O
(	O
1.64	O
±	O
0.87	O
days	O
)	O
in	O
comparison	O
to	O
the	O
placebo	B:C1696465
group	O
(	O
2.13	O
±	O
0.94	O
days	O
)	O
(	O
P	O
<	O
0.001	O
)	O
.	O

Average	O
amount	O
of	O
weight	B:C1262477
loss	I:C1262477
was	O
significantly	O
lower	O
in	O
the	O
synbiotic	O
group	O
in	O
comparison	O
to	O
that	O
in	O
the	O
placebo	O
group	O
(	O
129.5	O
±	O
23.388	O
grams	O
and	O
278	O
±	O
28.385	O
grams	O
,	O
resp	O
.	O
;	O
P	O
<	O
0.001	O
)	O
.	O

Average	O
amount	O
of	O
weight	O
loss	I:C1262477
was	O
significantly	O
lower	O
in	O
the	O
synbiotic	B:C2936470
group	O
in	O
comparison	O
to	O
that	O
in	O
the	O
placebo	O
group	O
(	O
129.5	O
±	O
23.388	O
grams	O
and	O
278	O
±	O
28.385	O
grams	O
,	O
resp	O
.	O
;	O
P	O
<	O
0.001	O
)	O
.	O

Average	O
amount	O
of	O
weight	O
loss	I:C1262477
was	O
significantly	O
lower	O
in	O
the	O
synbiotic	O
group	O
in	O
comparison	O
to	O
that	O
in	O
the	O
placebo	B:C1696465
group	O
(	O
129.5	O
±	O
23.388	O
grams	O
and	O
278	O
±	O
28.385	O
grams	O
,	O
resp	O
.	O
;	O
P	O
<	O
0.001	O
)	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
the	O
mean	O
duration	O
of	O
hospitalization	B:C0019993
in	O
both	O
groups	O
(	O
P	O
>	O
0.05	O
)	O
.	O

The	O
use	O
of	O
synbiotics	B:C2936470
as	O
an	O
adjuvant	O
therapy	I:C0677850
to	O
the	O
standard	O
treatment	O
of	O
dysentery	O
significantly	O
reduces	O
the	O
duration	O
of	O
dysentery	O
,	O
fever	O
,	O
and	O
rate	O
of	I:C1262477
weight	I:C1262477
losses	I:C1262477
.	O

The	O
use	O
of	O
synbiotics	O
as	O
an	O
adjuvant	B:C0677850
therapy	I:C0677850
to	O
the	O
standard	O
treatment	O
of	O
dysentery	O
significantly	O
reduces	O
the	O
duration	O
of	O
dysentery	O
,	O
fever	O
,	O
and	O
rate	O
of	I:C1262477
weight	I:C1262477
losses	I:C1262477
.	O

The	O
use	O
of	O
synbiotics	O
as	O
an	O
adjuvant	O
therapy	I:C0677850
to	O
the	O
standard	O
treatment	B:C0087111
of	O
dysentery	O
significantly	O
reduces	O
the	O
duration	O
of	O
dysentery	O
,	O
fever	O
,	O
and	O
rate	O
of	I:C1262477
weight	I:C1262477
losses	I:C1262477
.	O

The	O
use	O
of	O
synbiotics	O
as	O
an	O
adjuvant	O
therapy	I:C0677850
to	O
the	O
standard	O
treatment	O
of	O
dysentery	B:C0013369
significantly	O
reduces	O
the	O
duration	O
of	O
dysentery	O
,	O
fever	O
,	O
and	O
rate	O
of	I:C1262477
weight	I:C1262477
losses	I:C1262477
.	O

The	O
use	O
of	O
synbiotics	O
as	O
an	O
adjuvant	O
therapy	I:C0677850
to	O
the	O
standard	O
treatment	O
of	O
dysentery	O
significantly	O
reduces	O
the	O
duration	O
of	O
dysentery	B:C0013369
,	O
fever	O
,	O
and	O
rate	O
of	I:C1262477
weight	I:C1262477
losses	I:C1262477
.	O

The	O
use	O
of	O
synbiotics	O
as	O
an	O
adjuvant	O
therapy	I:C0677850
to	O
the	O
standard	O
treatment	O
of	O
dysentery	O
significantly	O
reduces	O
the	O
duration	O
of	O
dysentery	O
,	O
fever	B:C0015967
,	O
and	O
rate	O
of	I:C1262477
weight	I:C1262477
losses	I:C1262477
.	O

The	O
use	O
of	O
synbiotics	O
as	O
an	O
adjuvant	O
therapy	I:C0677850
to	O
the	O
standard	O
treatment	O
of	O
dysentery	O
significantly	O
reduces	O
the	O
duration	O
of	O
dysentery	O
,	O
fever	O
,	O
and	O
rate	B:C1262477
of	I:C1262477
weight	I:C1262477
losses	I:C1262477
.	O

The	O
trial	B:C0008976
is	O
registered	O
with	O
IRCT201109267647N1	O
.	O

The	O
trial	O
is	O
registered	B:C1514821
with	O
IRCT201109267647N1	O
.	O

